Kunal Parikh, PhD, is an assistant professor at the Johns Hopkins University (JHU) School of Medicine in the divisions of glaucoma and nanomedicine at the Wilmer Eye Institute and at the Center for Bioengineering Innovation and Design within the JHU Department of Biomedical Engineering. Dr. Parikh leads a translational, R01-funded, interdisciplinary lab of engineers, scientists, and clinicians working together to create and translate novel biomedical solutions to alleviate human suffering at scale. His research program utilizes biodesign and insight-informed innovation methodologies to develop digital health technologies, surgical instruments, medical devices, multi-functional biomaterials, and therapeutics that can be readily scaled and adopted into clinical practice to enable access to care, improve treatment outcomes, and prevent post-operative complications. Several of his laboratory’s inventions have been licensed to industry or formed the basis for startup companies (Eyedea Medical, Cove Therapeutics, Samata Therapeutics, Visilant), including multiple commercial products.

Previously, Dr. Parikh built and served as the executive director of the Social Innovation Lab at JHU, where he advised and funded mission-driven entrepreneurs. Prior to arriving in Baltimore, he was the founding CEO of Core Quantum Technologies, a venture-backed biotechnology company developing superior imaging and detection reagents. Dr. Parikh earned his PhD in biomedical engineering at JHU where he was a Roche/ARCS Scholar and National Science Foundation Graduate Research Fellow.